Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTP ICAP Regulatory News (TCAP)

Share Price Information for TP ICAP (TCAP)

Share Price is delayed by 15 minutes
Get Live Data
344.20    5.80 (1.71%)
Bid:
344.80
Ask:
345.20
Spread: 0.40 (0.116%)
Market Cap: £2.51b
TCAP Live PriceLast checked at - London Stock Exchange

Intraday TP ICAP Share Chart

Director/PDMR Shareholding

29 May 2025 16:15

RNS Number : 6672K
TP ICAP Group plc
29 May 2025
 

TP ICAP Group plc

LEI: 2138006YAA7IRVKKGE63

29 May 2025

TP ICAP Group plc (the 'Company' or 'TP ICAP')

 

Notification of transactions by persons discharging managerial responsibilities ('PDMRs')

On 27 May 2025 the Company received the following notifications relating to the vesting of awards granted on 25 May 2022 over ordinary shares of 25p each of the Company (the "Company Shares") under the rules of the TP ICAP Group plc Restricted Share Plan 2022 (the "2022 RSP").

Vesting of awards

Following the vesting on 27 May 2025 a total of 1,688,467 Company Shares were released by the TP ICAP Employee Benefit Trust ("EBT") to the PDMRs named in the table below, who then elected to sell a number of shares to settle the income tax and national insurance ("NI") liabilities and dealing charges arising upon the vesting of the awards. These market sales of the shares to discharge the income tax, NI liability and dealing charges incurred as a result of the awards vesting were completed on 27 May 2025.

A further two-year post-vesting holding period applies to the awards and the PDMRs listed below will not be permitted to sell any shares during this time.

The table below sets out the number of Company Shares released to each PDMR, the number subsequently sold to discharge the income tax, NI liability and dealing charges incurred as a result of their awards vesting, and the number retained by each PDMR.

PDMR

Nicolas Breteau

Philip Price

Robin Stewart

Title

Chief Executive

Officer

Group General Counsel

Chief Financial Officer

2022 RSP

Company Shares Released

768,883

464,405

455,179

Company Shares sold to discharge tax and NI liabilities and dealing charges

362,282

218,818

214,471

Sale price per Company Share (£)

£2.609763

£2.609763

£2.609763

Company Shares Retained

406,601

245,587

240,708

 

Notifications

The following notifications are made in accordance with the requirements of the UK Market Abuse Regulation and provides further detail.

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Nicolas Breteau

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Director and PDMR

b)

 

Initial notification /Amendment

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

TP ICAP Group plc

b)

 

LEI

 

 

2138006YAA7IRVKKGE63

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

Transaction 1

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

 

Ordinary shares of 25p each

 

JE00BMDZN391

b)

 

Nature of the transaction

 

 

Transfer of ordinary shares of 25p each in TP ICAP Group plc from the TP ICAP Employee Benefit Trust to the PDMR following the vesting of the TP ICAP Group plc Restricted Share Plan 2022 award.

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

£nil

768,883

d)

 

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

 

768,883

 

 

£nil

e)

 

Date of the transaction

 

 

27May 2025

f)

 

Place of the transaction

Outside a trading venue

Transaction 2

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

 

Ordinary shares of 25p each

 

JE00BMDZN391

b)

 

Nature of the transaction

 

 

Sale of ordinary shares of 25p each in TP ICAP Group plc to meet the income tax and national insurance liabilities and dealing charges arising upon the vesting of the TP ICAP Group plc Restricted Share Plan 2022 award.

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

£2.609763

362,282

d)

 

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

 

362,282

 

£2.609763

e)

 

Date of the transaction

 

 

27 May 2025

f)

 

Place of the transaction

London Stock Exchange

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Philip Price

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Director and PDMR

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

TP ICAP Group plc

b)

 

LEI

 

 

2138006YAA7IRVKKGE63

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

Transaction 1

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

 

Ordinary shares of 25p each

 

JE00BMDZN391

b)

 

Nature of the transaction

 

 

Transfer of ordinary shares of 25p each in TP ICAP Group plc from the TP ICAP Employee Benefit Trust to the PDMR following the vesting of the TP ICAP Group plc Restricted Share Plan 2022 award.

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

£nil

464,405

d)

 

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

 

464,405

 

 

£nil

 

e)

 

Date of the transaction

 

 

27 May 2025

f)

 

Place of the transaction

Outside a trading venue

Transaction 2

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

 

Ordinary shares of 25p each

 

JE00BMDZN391

b)

 

Nature of the transaction

 

 

Sale of ordinary shares of 25p each in TP ICAP Group plc to meet the income tax and national insurance liabilities and dealing charges arising upon the vesting of the TP ICAP Group plc Restricted Share Plan 2022 award.

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

£2.609763

218,818

d)

 

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

 

 

218,818

 

 

£2.609763

e)

 

Date of the transaction

 

 

27 May 2025

f)

 

Place of the transaction

London Stock Exchange

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Robin Stewart

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Director and PDMR

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

TP ICAP Group plc

b)

 

LEI

 

 

2138006YAA7IRVKKGE63

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

Transaction 1

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

 

Ordinary shares of 25p each

 

JE00BMDZN391

b)

 

Nature of the transaction

 

 

Transfer of ordinary shares of 25p each in TP ICAP Group plc from the TP ICAP Employee Benefit Trust to the PDMR following the vesting of the TP ICAP Group plc Restricted Share Plan 2022 award.

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

£nil

455,179

d)

 

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

 

455,179

 

 

£nil

 

e)

 

Date of the transaction

 

 

27 May 2025

f)

 

Place of the transaction

Outside a trading venue

Transaction 2

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

 

Ordinary shares of 25p each

 

JE00BMDZN391

b)

 

Nature of the transaction

 

 

Sale of ordinary shares of 25p each in TP ICAP Group plc to meet the income tax and national insurance liabilities and dealing charges arising upon the vesting of the TP ICAP Group plc Restricted Share Plan 2022 award.

 

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

Volume(s)

£2.609763

[x]214,471

d)

 

Aggregated information

 

- Aggregated volume

 

 

- Price

 

 

 

214,471

 

£2.609763

e)

 

Date of the transaction

 

 

27 May 2025

f)

 

Place of the transaction

London Stock Exchange

 

Enquiries

Vicky Hart

Group Company Secretary

+44 (0) 20 7200 7117

companysecretarial@tpicap.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHSEFFLUEISEII
Date   Source Headline
12th May 20204:26 pmRNSHolding(s) in Company
23rd Apr 20204:30 pmRNSHolding(s) in Company
17th Apr 202012:09 pmRNSAnnual Financial Report
1st Apr 20207:00 amRNSDirector/PDMR Shareholding - Replacement
24th Mar 20207:00 amRNSDirectorate Change
20th Mar 20207:00 amRNSHolding(s) in Company
17th Mar 202010:52 amRNSHolding(s) in Company
10th Mar 20207:00 amRNSFinal Results
6th Mar 20207:00 amRNSDirectorate Change
18th Feb 20202:54 pmRNSHolding(s) in Company
18th Feb 20207:00 amRNSDirectorate Change
23rd Jan 20205:33 pmRNSHolding(s) in Company
16th Jan 20202:34 pmRNSHolding(s) in Company
24th Dec 20197:00 amRNSProposed acquisition of Louis Capital
23rd Dec 20197:00 amRNSIntroduction of a new Jersey incorporated HoldCo
11th Dec 20199:29 amRNSHolding(s) in Company
1st Nov 20191:58 pmRNSHolding(s) in Company
1st Nov 20197:00 amRNSTrading Statement
31st Oct 20197:00 amRNSTotal Voting Rights
18th Oct 20197:10 amRNSDirectorate Change
11th Oct 20197:00 amRNSSettlement of FCA Investigation
7th Oct 20198:50 amRNSHolding(s) in Company
27th Sep 20197:00 amRNSDirector Declaration and Board Change
19th Sep 20192:22 pmRNSHolding(s) in Company
16th Sep 20194:13 pmRNSAcquisition
14th Aug 20194:41 pmRNSDirector/PDMR Shareholding
6th Aug 20197:00 amRNSFinancial and Interim Management Report
28th Jun 20193:26 pmRNSDirector/PDMR Shareholding
6th Jun 20194:08 pmRNSDirector/PDMR Shareholding
28th May 20191:20 pmRNSPublication of Final Terms
24th May 201910:38 amRNSResult of Tender Offer
16th May 201910:58 amRNSTender Offer
15th May 20195:45 pmRNSPublication of a Prospectus
15th May 20194:41 pmRNSConfirmation of Richard Berliand as Chairman
15th May 20194:37 pmRNSResult of AGM
15th May 20197:00 amRNSAGM Statement and Trading Update
12th Apr 20191:17 pmRNSDirector/PDMR Shareholding
3rd Apr 20195:35 pmRNSDirector/PDMR Shareholding
19th Mar 20197:01 amRNSConfirmation of Director Appointment
19th Mar 20197:00 amRNSFinal Results
1st Mar 20192:58 pmRNSHolding(s) in Company
28th Feb 20192:22 pmRNSHolding(s) in Company
21st Feb 20194:14 pmRNSHolding(s) in Company
7th Feb 20194:15 pmRNSHolding(s) in Company
29th Jan 20192:13 pmRNSStatement re Press Release
28th Jan 20195:00 pmRNSHolding(s) in Company
25th Jan 20197:00 amRNSBoard Committee Changes
17th Jan 20199:17 amRNSHolding(s) in Company
14th Dec 20181:52 pmRNSHolding(s) in Company
14th Dec 20187:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.